CATEGORY

GLP-1 & Metabolic

8 compounds tracked in this category with source-backed claims and regulatory status.

5-Amino-1MQ editorial research scene

5-Amino-1MQ

5-Amino-1MQ (5-amino-1-methylquinoline) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cell...

AOD-9604 editorial research scene

AOD-9604

AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment of human growth hormone (hGH) residues 177-191, developed by Metabo...

Dihexa editorial research scene

Dihexa

Dihexa (N-hexanoic-tyr-ile-(6) aminohexanoic amide) is a metabolically stabilized analog of angiotensin IV developed by researchers at Washi...

Metformin editorial research scene

Metformin

Metformin is an FDA-approved biguanide antidiabetic (marketed as Glucophage and generics) used as first-line therapy for Type 2 diabetes. It...

MOTS-c editorial research scene

MOTS-c

MOTS-c is a peptide topic commonly associated with metabolic and longevity discussions online. This starter page keeps the topic in the revi...

Retatrutide editorial research scene

Retatrutide

Retatrutide is an investigational triple-agonist peptide (GLP-1, GIP, and glucagon receptor agonist) developed by Eli Lilly that showed sign...

Semaglutide editorial research scene

Semaglutide

Semaglutide (Ozempic/Wegovy/Rybelsus) is a GLP-1 receptor agonist developed by Novo Nordisk, FDA-approved for Type 2 diabetes and chronic we...

Tirzepatide editorial research scene

Tirzepatide

Tirzepatide (Mounjaro/Zepbound) is a dual GIP and GLP-1 receptor agonist developed by Eli Lilly, FDA-approved for Type 2 diabetes and chroni...